Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-10-07 07:45 am Sale |
2022-10-04 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 72,160 3.440% |
-497,641![]() (-87.34%) |
Filing History |
2022-08-19 4:30 pm Unchanged |
2022-08-18 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 569,801 7.100% |
0 (Unchanged) |
Filing History |
2022-08-03 4:17 pm Unchanged |
2022-08-03 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 569,801 7.100% |
0 (Unchanged) |
Filing History |
2022-07-22 2:21 pm Purchase |
2022-07-20 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 569,801 7.100% |
58,974![]() (+11.54%) |
Filing History |
2022-06-17 4:30 pm Unchanged |
2022-06-15 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 510,827 6.400% |
0 (Unchanged) |
Filing History |
2022-05-25 5:01 pm Purchase |
2022-05-24 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 510,827 6.400% |
178,056![]() (+53.51%) |
Filing History |
2022-05-10 4:58 pm Unchanged |
2022-05-09 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
2022-05-02 5:27 pm Unchanged |
2022-04-28 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
2022-04-21 1:09 pm Unchanged |
2022-04-20 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.170% |
0 (Unchanged) |
Filing History |
2022-03-16 08:00 am Unchanged |
2022-03-15 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
0 (Unchanged) |
Filing History |
2022-03-07 3:53 pm Unchanged |
2022-03-04 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
0 (Unchanged) |
Filing History |
2022-02-28 1:16 pm Purchase |
2022-02-24 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 332,771 4.180% |
18,178![]() (+5.78%) |
Filing History |
2022-02-22 7:04 pm Purchase |
2022-02-22 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 314,592 3.950% |
116,727![]() (+58.99%) |
Filing History |
2022-01-27 11:56 am Unchanged |
2022-01-26 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 197,866 2.480% |
0 (Unchanged) |
Filing History |
2022-01-05 5:29 pm Purchase |
2022-01-04 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 197,866 2.480% |
30,424![]() (+18.17%) |
Filing History |
2021-10-25 9:08 pm Purchase |
2021-10-25 | 13D | Catalyst Biosciences, Inc. CBIO |
SINGER JULIAN D. | 167,442 2.110% |
66,323![]() (+65.59%) |
Filing History |
2021-03-19 6:51 pm Sale |
2021-03-17 | 13G | HC2 Holdings, Inc. HCHC |
SINGER JULIAN D. | 0 0.000% |
-3,262,514![]() (Position Closed) |
Filing History |
2020-08-03 07:33 am Sale |
2020-08-03 | 13G | HC2 Holdings, Inc. HCHC |
SINGER JULIAN D. | 3,262,514 6.800% |
-115,583![]() (-3.42%) |
Filing History |
2020-05-18 9:02 pm Purchase |
2020-05-13 | 13D | HC2 Holdings, Inc. HCHC |
SINGER JULIAN D. | 3,378,097 7.260% |
303,245![]() (+9.86%) |
Filing History |